Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.
Chem Biol
; 14(10): 1186-97, 2007 Oct.
Article
em En
| MEDLINE
| ID: mdl-17961830
ABSTRACT
The two subunits of core binding factor (Runx1 and CBFbeta) play critical roles in hematopoiesis and are frequent targets of chromosomal translocations found in leukemia. The binding of the CBFbeta-smooth muscle myosin heavy chain (SMMHC) fusion protein to Runx1 is essential for leukemogenesis, making this a viable target for treatment. We have developed inhibitors with low micromolar affinity which effectively block binding of Runx1 to CBFbeta. NMR-based docking shows that these compounds bind to CBFbeta at a site displaced from the binding interface for Runx1, that is, these compounds function as allosteric inhibitors of this protein-protein interaction, a potentially generalizable approach. Treatment of the human leukemia cell line ME-1 with these compounds shows decreased proliferation, indicating these are good candidates for further development.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Leucemia
/
Proliferação de Células
/
Inibidores Enzimáticos
/
Sítio Alostérico
/
Subunidade alfa 2 de Fator de Ligação ao Core
/
Subunidade beta de Fator de Ligação ao Core
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article